Project Grant HT94252510923
Award Date 9/1/25
Completion Date 8/31/27
Dollars Obligated $609K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
- This Project Grant award of $757,497 from the Defense Health Agency will support research by Drexel University in Philadelphia, PA to investigate the "ROLE OF PERILESIONAL REACTIVE ASTROCYTOSIS IN MELANOMA BRAIN METASTASES". The project is funded under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform healthcare for Service Members and the American public. Drexel University has extensive...
- This $819,195 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by Drexel University on the PEDF PLXDC1 ADNP signaling pathways related to neuromorphogenesis and neural circuit development. The award, which runs from September 15, 2023 to September 14, 2026, will fund basic, translational, and clinical research aimed at advancing scientific understanding and developing new treatments in areas such as...
- This Project Grant award of $668,038.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports Drexel University's research on "BIOMIMETIC NANOPARTICLE-MEDIATED DELIVERY OF IMMUNOMODULATING NUCLEIC ACIDS AS A STRATEGY TO ANTICIPATE MELANOMA DRUG RESISTANCE." The 3-year project aims to develop innovative nanoparticle-based therapies to overcome drug resistance in melanoma treatment. As a private research university, Drexel has a...
- Drexel University was awarded a $302,750 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from March 2021 through March 2024 to develop a novel microtubule-based hypothesis for frontotemporal dementia leading to potential therapies for military personnel and veterans. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform...
- The Defense Health Agency awarded Duke University a $804,999 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to support research on "DETECTING MISSED METASTASES FROM NOMINALLY EARLY-STAGE MELANOMAS WITH PUMP-PROBE MICROSCOPY". The award runs from September 1, 2023 to August 31, 2026. The Project Grant enables Duke's research to transform health care for Service Members and the American public through innovative and impactful biomedical research...
- This $161,000 federal Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research at Duke University to investigate "Breast Cancer Brain Metastases: Integrating Immunogenomic and Phenotypic Vulnerabilities to Improve Outcomes." The research aims to develop innovative approaches to understand complex biological systems, create new diagnostic tools, and explore potential therapeutic interventions...
- The Defense Health Agency awarded Duke University a $1,167,250 Project Grant (CFDA 12.420 - Military Medical Research and Development) with a performance period from June 1, 2024 to May 31, 2027. The grant funding supports Duke's research on the role of the NLRP3-NLRC5 signaling pathway in melanoma immune evasion and dormancy. The research aims to advance the understanding of mechanisms underlying melanoma progression, with the potential to inform new therapeutic approaches. As a prominent...
- This Project Grant award in the amount of $679,085.00 was issued by the Defense Health Agency, a component of the Department of Defense, under the Military Medical Research and Development program (CFDA 12.420). The funding supports research by Temple University-Of The Commonwealth System Of Higher Education, through its division Temple University, to investigate the role of tumor-associated sensory neurons in breast cancer invasion and metastasis. The award period runs from January 15, 2024...
- The Defense Health Agency awarded Duke University a $402,500 Project Grant under the Military Medical Research and Development program (CFDA 12.420) for the period of June 1, 2023 through May 31, 2025. The grant will support Duke University's research efforts to target the ferropotosis protection mechanism of serum to disable cancer metastasis. The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions for both...
- The Department of Defense's Defense Health Agency awarded a $4,818,759 Project Grant to Duke University under the Military Medical Research and Development program (CFDA 12.420) for the project "SINGLE-CELL AND SPATIAL ANALYSIS OF LETHAL BREAST CANCERS". The grant, awarded on April 1, 2024, will fund research to improve understanding and treatment of lethal breast cancers through advanced single-cell and spatial analysis techniques. This work supports the program's goals of...